MedTrace Logo

Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears

NCT00266734 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2010-02-11

No results posted yet for this study

Summary

To compare the efficacy of a recently FDA approved point of care diagnostic test, the RPS Adeno Detector (Rapid Pathogen Screening, Inc.; South Williamsport, PA), against cell culture for detecting adenoviral conjunctivitis

Conditions

  • Acute Conjunctivitis
  • Adenoviral Conjunctivitis

Interventions

DEVICE

RPS Adeno Detector

Sponsors & Collaborators

  • Rapid Pathogen Screening

    lead INDUSTRY

Principal Investigators

  • Elisabeth J Cohen, MD · Wills Eye Hospital

  • Shachar Tauber, MD · St Johns Ophthalmology Clinic, Springfield, MO

  • Frank Schirra, MD · Universitätsklinikum des Saarlandes, Klinik für Augenheilkunde, Homburg, Germany

  • Kristian Kozich, MD · University of Erlangen-Nurnberg, Erlangen, Germany

  • Richard Davidson, MD · University of Colorado Health Science Center, Denver, CO

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Completion
2005-09-30

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00266734 on ClinicalTrials.gov